# Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-study-of-carfilzomib-and-dexamethasone-therapy-for-newly-diagnosed/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Peter A. Forsberg,Adriana Rossi,Angelique Boyer,Linda Tegnestam,Roger Pearse,Arthur W. Perry,Karen Pekle,David Jayabalan,Scott Ely,Leora Boussi,Daniel W. Sherbenou,Colt Williams,John N. Allan,Morton Coleman,Rubén Niesvizky,Tomer M. Mark |
| Citations | 6 |
| DOI | 10.1002/ajh.25435 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.25435 |
| OpenAlex ID | https://openalex.org/W2913899003 |
| PMID | 30740766 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Colt Williams](https://scholariq.org/researchers/colt-williams/)

## Paper journal

- [American Journal of Hematology](https://scholariq.org/journals/american-journal-of-hematology/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.